▶ 調査レポート

世界の神経因性疼痛治療薬市場：市場規模・現状・予測
• 英文タイトル：Global Neuropathic Pain Drugs Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の神経因性疼痛治療薬市場：市場規模・現状・予測 / Global Neuropathic Pain Drugs Market Size, Status and Forecast 2019-2025 / QYR9N7659資料のイメージです。• レポートコード：QYR9N7659
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、神経因性疼痛治療薬のグローバル市場について調査・分析したレポートで、種類別（三環系抗うつ薬抗けいれん薬、セロトニン - ノルエピネフリン再取り込み阻害薬、カプサイシンクリーム、局所麻酔、オピオイド、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・神経因性疼痛治療薬の世界市場規模
・主要企業別市場シェア
・神経因性疼痛治療薬の世界市場規模：種類別（三環系抗うつ薬抗けいれん薬、セロトニン - ノルエピネフリン再取り込み阻害薬、カプサイシンクリーム、局所麻酔、オピオイド、その他）
・神経因性疼痛治療薬の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局）
・神経因性疼痛治療薬のアメリカ市場規模（種類別、用途別）
・神経因性疼痛治療薬のヨーロッパ市場規模（種類別、用途別）
・神経因性疼痛治療薬の中国市場規模（種類別、用途別）
・神経因性疼痛治療薬の日本市場規模（種類別、用途別）
・神経因性疼痛治療薬の東南アジア市場規模（種類別、用途別）
・神経因性疼痛治療薬のインド市場規模（種類別、用途別）
・神経因性疼痛治療薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・神経因性疼痛治療薬の世界市場予測（2019年-2025年）
・神経因性疼痛治療薬の地域別市場予測（2019年-2025年）
...

Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia).In terms of value, North America is a large market and is expected to increase at over 5% CAGR during the forecast period. The Asia Pacific neuropathic pain management market is projected to show fast growth and it is projected grow at CAGR of 6% over the forecast period due to increasing prevalence of diabetes in Asia Pacific, particularly in China and India.
In 2018, the global Neuropathic Pain Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Neuropathic Pain Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neuropathic Pain Drugs development in United States, Europe and China.

The key players covered in this study
Pfizer
Johnson & Johnson
Sanofi
GlaxoSmithKline
Eli Lilly
Bristol-Myers Squibb
Biogen
Baxter Healthcare
Depomed

Market segment by Type, the product can be split into
Tricyclic Anti-Depressants Anticonvulsants
Serotonin-Norepinephrine Reuptake Inhibitor
Capsaicin Cream
Local Anaesthesia
Opioids
Steroids
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Neuropathic Pain Drugs status, future forecast, growth opportunity, key market and key players.
To present the Neuropathic Pain Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Neuropathic Pain Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Neuropathic Pain Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Tricyclic Anti-Depressants Anticonvulsants
1.4.3 Serotonin-Norepinephrine Reuptake Inhibitor
1.4.4 Capsaicin Cream
1.4.5 Local Anaesthesia
1.4.6 Opioids
1.4.7 Steroids
1.4.8 Others
1.5 Market by Application
1.5.1 Global Neuropathic Pain Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Neuropathic Pain Drugs Market Size
2.2 Neuropathic Pain Drugs Growth Trends by Regions
2.2.1 Neuropathic Pain Drugs Market Size by Regions (2014-2025)
2.2.2 Neuropathic Pain Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Neuropathic Pain Drugs Market Size by Manufacturers
3.1.1 Global Neuropathic Pain Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Neuropathic Pain Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Neuropathic Pain Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Neuropathic Pain Drugs Key Players Head office and Area Served
3.3 Key Players Neuropathic Pain Drugs Product/Solution/Service
3.4 Date of Enter into Neuropathic Pain Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Neuropathic Pain Drugs Market Size by Type (2014-2019)
4.2 Global Neuropathic Pain Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Neuropathic Pain Drugs Market Size (2014-2019)
5.2 Neuropathic Pain Drugs Key Players in United States
5.3 United States Neuropathic Pain Drugs Market Size by Type
5.4 United States Neuropathic Pain Drugs Market Size by Application

6 Europe
6.1 Europe Neuropathic Pain Drugs Market Size (2014-2019)
6.2 Neuropathic Pain Drugs Key Players in Europe
6.3 Europe Neuropathic Pain Drugs Market Size by Type
6.4 Europe Neuropathic Pain Drugs Market Size by Application

7 China
7.1 China Neuropathic Pain Drugs Market Size (2014-2019)
7.2 Neuropathic Pain Drugs Key Players in China
7.3 China Neuropathic Pain Drugs Market Size by Type
7.4 China Neuropathic Pain Drugs Market Size by Application

8 Japan
8.1 Japan Neuropathic Pain Drugs Market Size (2014-2019)
8.2 Neuropathic Pain Drugs Key Players in Japan
8.3 Japan Neuropathic Pain Drugs Market Size by Type
8.4 Japan Neuropathic Pain Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Neuropathic Pain Drugs Market Size (2014-2019)
9.2 Neuropathic Pain Drugs Key Players in Southeast Asia
9.3 Southeast Asia Neuropathic Pain Drugs Market Size by Type
9.4 Southeast Asia Neuropathic Pain Drugs Market Size by Application

10 India
10.1 India Neuropathic Pain Drugs Market Size (2014-2019)
10.2 Neuropathic Pain Drugs Key Players in India
10.3 India Neuropathic Pain Drugs Market Size by Type
10.4 India Neuropathic Pain Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Neuropathic Pain Drugs Market Size (2014-2019)
11.2 Neuropathic Pain Drugs Key Players in Central & South America
11.3 Central & South America Neuropathic Pain Drugs Market Size by Type
11.4 Central & South America Neuropathic Pain Drugs Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Neuropathic Pain Drugs Introduction
12.1.4 Pfizer Revenue in Neuropathic Pain Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Neuropathic Pain Drugs Introduction
12.2.4 Johnson & Johnson Revenue in Neuropathic Pain Drugs Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Neuropathic Pain Drugs Introduction
12.3.4 Sanofi Revenue in Neuropathic Pain Drugs Business (2014-2019)
12.3.5 Sanofi Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Details
12.4.2 Company Description and Business Overview
12.4.3 Neuropathic Pain Drugs Introduction
12.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Drugs Business (2014-2019)
12.4.5 GlaxoSmithKline Recent Development
12.5 Eli Lilly
12.5.1 Eli Lilly Company Details
12.5.2 Company Description and Business Overview
12.5.3 Neuropathic Pain Drugs Introduction
12.5.4 Eli Lilly Revenue in Neuropathic Pain Drugs Business (2014-2019)
12.5.5 Eli Lilly Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Company Details
12.6.2 Company Description and Business Overview
12.6.3 Neuropathic Pain Drugs Introduction
12.6.4 Bristol-Myers Squibb Revenue in Neuropathic Pain Drugs Business (2014-2019)
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Biogen
12.7.1 Biogen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Neuropathic Pain Drugs Introduction
12.7.4 Biogen Revenue in Neuropathic Pain Drugs Business (2014-2019)
12.7.5 Biogen Recent Development
12.8 Baxter Healthcare
12.8.1 Baxter Healthcare Company Details
12.8.2 Company Description and Business Overview
12.8.3 Neuropathic Pain Drugs Introduction
12.8.4 Baxter Healthcare Revenue in Neuropathic Pain Drugs Business (2014-2019)
12.8.5 Baxter Healthcare Recent Development
12.9 Depomed
12.9.1 Depomed Company Details
12.9.2 Company Description and Business Overview
12.9.3 Neuropathic Pain Drugs Introduction
12.9.4 Depomed Revenue in Neuropathic Pain Drugs Business (2014-2019)
12.9.5 Depomed Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Neuropathic Pain Drugs Key Market Segments
Table Key Players Neuropathic Pain Drugs Covered
Table Global Neuropathic Pain Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Neuropathic Pain Drugs Market Size Market Share by Type 2014-2025
Figure Tricyclic Anti-Depressants Anticonvulsants Figures
Table Key Players of Tricyclic Anti-Depressants Anticonvulsants
Figure Serotonin-Norepinephrine Reuptake Inhibitor Figures
Table Key Players of Serotonin-Norepinephrine Reuptake Inhibitor
Figure Capsaicin Cream Figures
Table Key Players of Capsaicin Cream
Figure Local Anaesthesia Figures
Table Key Players of Local Anaesthesia
Figure Opioids Figures
Table Key Players of Opioids
Figure Steroids Figures
Table Key Players of Steroids
Figure Others Figures
Table Key Players of Others
Table Global Neuropathic Pain Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Neuropathic Pain Drugs Report Years Considered
Table Global Neuropathic Pain Drugs Market Size 2014-2025 (Million US$)
Figure Global Neuropathic Pain Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Neuropathic Pain Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Neuropathic Pain Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Neuropathic Pain Drugs Market Share by Regions 2014-2019
Figure Global Neuropathic Pain Drugs Market Share by Regions 2014-2019
Figure Global Neuropathic Pain Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Neuropathic Pain Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Neuropathic Pain Drugs Market Share by Manufacturers (2014-2019)
Figure Global Neuropathic Pain Drugs Market Share by Manufacturers in 2018
Table Global Neuropathic Pain Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Neuropathic Pain Drugs Product/Solution/Service
Table Date of Enter into Neuropathic Pain Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Neuropathic Pain Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Neuropathic Pain Drugs Market Size Share by Type (2014-2019)
Figure Global Neuropathic Pain Drugs Market Size Market Share by Type (2014-2019)
Table Global Neuropathic Pain Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Neuropathic Pain Drugs Market Size Share by Application (2014-2019)
Figure Global Neuropathic Pain Drugs Market Size Market Share by Application (2014-2019)
Figure Global Neuropathic Pain Drugs Revenue Market Share by Application in 2018
Figure United States Neuropathic Pain Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Neuropathic Pain Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Neuropathic Pain Drugs Market Share (2018-2019)
Table United States Neuropathic Pain Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Neuropathic Pain Drugs Market Share by Type (2014-2019)
Table United States Neuropathic Pain Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Neuropathic Pain Drugs Market Share by Application (2014-2019)
Figure Europe Neuropathic Pain Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Neuropathic Pain Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Neuropathic Pain Drugs Market Share (2018-2019)
Table Europe Neuropathic Pain Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Neuropathic Pain Drugs Market Share by Type (2014-2019)
Table Europe Neuropathic Pain Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Neuropathic Pain Drugs Market Share by Application (2014-2019)
Figure China Neuropathic Pain Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Neuropathic Pain Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Neuropathic Pain Drugs Market Share (2018-2019)
Table China Neuropathic Pain Drugs Market Size by Type (2014-20189) (Million US$)
Table China Neuropathic Pain Drugs Market Share by Type (2014-2019)
Table China Neuropathic Pain Drugs Market Size by Application (2014-2019) (Million US$)
Table China Neuropathic Pain Drugs Market Share by Application (2014-2019)
Figure Japan Neuropathic Pain Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Neuropathic Pain Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Neuropathic Pain Drugs Market Share (2018-2019)
Table Japan Neuropathic Pain Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Neuropathic Pain Drugs Market Share by Type (2014-2019)
Table Japan Neuropathic Pain Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Neuropathic Pain Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Neuropathic Pain Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Neuropathic Pain Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Neuropathic Pain Drugs Market Share (2018-2019)
Table Southeast Asia Neuropathic Pain Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Neuropathic Pain Drugs Market Share by Type (2014-2019)
Table Southeast Asia Neuropathic Pain Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Neuropathic Pain Drugs Market Share by Application (2014-2019)
Figure India Neuropathic Pain Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Neuropathic Pain Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Neuropathic Pain Drugs Market Share (2018-2019)
Table India Neuropathic Pain Drugs Market Size by Type (2014-2019) (Million US$)
Table India Neuropathic Pain Drugs Market Share by Type (2014-2019)
Table India Neuropathic Pain Drugs Market Size by Application (2014-2019) (Million US$)
Table India Neuropathic Pain Drugs Market Share by Application (2014-2019)
Figure Central & South America Neuropathic Pain Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Neuropathic Pain Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Neuropathic Pain Drugs Market Share (2018-2019)
Table Central & South America Neuropathic Pain Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Neuropathic Pain Drugs Market Share by Type (2014-2019)
Table Central & South America Neuropathic Pain Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Neuropathic Pain Drugs Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Neuropathic Pain Drugs Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Neuropathic Pain Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Neuropathic Pain Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Neuropathic Pain Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Neuropathic Pain Drugs Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Neuropathic Pain Drugs Business (2014-2019)
Table Sanofi Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Neuropathic Pain Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Neuropathic Pain Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Neuropathic Pain Drugs Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Neuropathic Pain Drugs Business (2014-2019)
Table Eli Lilly Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Neuropathic Pain Drugs Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Neuropathic Pain Drugs Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Biogen Company Details
Table Biogen Revenue in Neuropathic Pain Drugs Business (2014-2019)(Million US$)
Figure Biogen Revenue Growth Rate in Neuropathic Pain Drugs Business (2014-2019)
Table Biogen Recent Development
Table Baxter Healthcare Company Details
Table Baxter Healthcare Revenue in Neuropathic Pain Drugs Business (2014-2019)(Million US$)
Figure Baxter Healthcare Revenue Growth Rate in Neuropathic Pain Drugs Business (2014-2019)
Table Baxter Healthcare Recent Development
Table Depomed Company Details
Table Depomed Revenue in Neuropathic Pain Drugs Business (2014-2019)(Million US$)
Figure Depomed Revenue Growth Rate in Neuropathic Pain Drugs Business (2014-2019)
Table Depomed Recent Development
Table Global Neuropathic Pain Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Neuropathic Pain Drugs Market Size Share by Regions (2019-2025)
Figure Global Neuropathic Pain Drugs Market Size Share by Regions in 2025
Figure United States Neuropathic Pain Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Neuropathic Pain Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Neuropathic Pain Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Neuropathic Pain Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Neuropathic Pain Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Neuropathic Pain Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Neuropathic Pain Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Neuropathic Pain Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Neuropathic Pain Drugs Market Size by Product (2019-2025)
Figure Global Neuropathic Pain Drugs Market Size by Product in 2025
Table Global Neuropathic Pain Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Neuropathic Pain Drugs Market Size by Application (2019-2025)
Figure Global Neuropathic Pain Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の鎮痛剤デリバリー市場：市場規模・現状・予測
    Global Pain Drug Delivery Market Size, Status and Forecast 2019-2025
    QYR9N7754 2019年6月14日 94Pages
    当資料は、鎮痛剤デリバリーのグローバル市場について調査・分析したレポートで、種類別（経皮ドラッグデリバリーシステム、髄腔内ドラッグデリバリーシステム、その他）、用途別（腫瘍学、神経学的障害、肺疾患、ホルモン障害、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市...
  • 世界の関節痛の注射市場：市場規模・現状・予測
    Global Joint Pain Injections Market Size, Status and Forecast 2019-2025
    QYR9N7419 2019年6月14日 94Pages
    当資料は、関節痛の注射のグローバル市場について調査・分析したレポートで、種類別（コルチコステロイド注射、ヒアルロン酸注射）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界の局所疼痛緩和市場：市場規模・現状・予測
    Global Topical Pain Relief Market Size, Status and Forecast 2019-2025
    QYR9N8130 2019年6月14日 99Pages
    当資料は、局所疼痛緩和のグローバル市場について調査・分析したレポートで、種類別（非オピオイド、オピオイド）、用途別（薬局・ドラッグストア、電子商取引、小売店・食料品店）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界の非カタプレキシーナルコレプシー薬市場：市場規模・現状・予測
    Global Non Cataplexy Narcolepsy Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7681 2019年6月14日 93Pages
    当資料は、非カタプレキシーナルコレプシー薬のグローバル市場について調査・分析したレポートで、種類別（抗酸化薬、覚せい剤、その他）、用途別（子供（18歳未満）、成人（18〜50歳）、高齢者（50歳以上）、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測...
  • 世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測
    Global Myelodysplastic Syndrome (MDS) Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7611 2019年6月14日 96Pages
    当資料は、骨髄異形成症候群（MDS）薬のグローバル市場について調査・分析したレポートで、種類別（低メチル化剤、免疫調節薬、抗貧血薬）、用途別（オリジナル、ジェネリック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界のテネクテプラーゼ薬市場：市場規模・現状・予測
    Global Tenecteplase Drugs Market Size, Status and Forecast 2019-2025
    QYR9N8112 2019年6月14日 93Pages
    当資料は、テネクテプラーゼ薬のグローバル市場について調査・分析したレポートで、種類別（静脈内投与量、カテーテル内点滴注入量）、用途別（病院、診療所、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界の鼻出血薬市場：市場規模・現状・予測
    Global Epistaxis Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7169 2019年6月14日 99Pages
    当資料は、鼻出血薬のグローバル市場について調査・分析したレポートで、種類別（血管収縮薬、麻酔薬、抗生物質軟膏、焼灼剤、その他）、用途別（病院、診療所、小売薬局、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界の凍結乾燥注射薬市場：市場規模・現状・予測
    Global Lyophilized Injectable Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7487 2019年6月14日 96Pages
    当資料は、凍結乾燥注射薬のグローバル市場について調査・分析したレポートで、種類別（使い捨てバイアル、ポイントオブケア再構成、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のチロシンヒドロキシラーゼ欠乏薬市場：市場規模・現状・予測
    Global Tyrosine Hydroxylase Deficiency Drugs Market Size, Status and Forecast 2019-2025
    QYR9N8151 2019年6月14日 99Pages
    当資料は、チロシンヒドロキシラーゼ欠乏薬のグローバル市場について調査・分析したレポートで、種類別（トリヘキシフェニジル、アマンタジン、その他）、用途別（病院、診療所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界の黄斑変性症の薬市場：市場規模・現状・予測
    Global Macular Degeneration Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7493 2019年6月14日 97Pages
    当資料は、黄斑変性症の薬のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、アイリーア、アバスチン、スクアラミン、Concecept、その他）、用途別（50〜60歳、60〜70歳、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場...
  • 世界の一般麻酔薬市場：市場規模・現状・予測世界の一般麻酔薬市場：市場規模・現状・予測 General Anaesthesia Drugs act on the central nervous system, inducing a sedative state in patients who are to go through a surgical procedure.In 2018, the global General Anaesthesia Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx%…
  • 世界の局所疼痛緩和市場：市場規模・現状・予測世界の局所疼痛緩和市場：市場規模・現状・予測 Pain is a distressing feeling which is usually caused by intense or damaging stimuli. Pain is most prevalent symptom associated with most of chronic conditions. Pain management involves the employment of medications or analgesics and therapies to treat several pain conditions. Whenever, these medica…
  • 世界の非ステロイド系抗炎症薬（NSAID）市場：市場規模・現状・予測世界の非ステロイド系抗炎症薬（NSAID）市場：市場規模・現状・予測 Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
  • 世界のセロトニン症候群市場：市場規模・現状・予測世界のセロトニン症候群市場：市場規模・現状・予測 Serotonin syndrome is a group of symptoms such as high body temperature, agitation, increased reflexes, tremor, sweating, dilated pupils, diarrhoea etc. due to use of serotonergic drugs. Serious complications such as seizures and extensive muscle breakdown may occur which may lead to death.US accoun…
  • 世界のセロトニン症候群の治療市場：市場規模・現状・予測世界のセロトニン症候群の治療市場：市場規模・現状・予測 Serotonin syndrome refers to a group of symptoms and signs caused by the hyperfunction of serotonin in the nervous system, which is manifested as the triad of cognitive function/behavior change, neuromuscular abnormality and autonomic nervous instability.In 2018, the global Serotonin Syndrome Treatm…